# PHARMACEUTICAL COMPOSITIONS

## Abstract
A pharmaceutical composition for sublingual adminis tration comprising buprenorphine or a non toxic salt thereof dissolved in 20 30 v v aqueous ethanol buffered to be tween pH 4.5 to 5.5 with 0.05 to 0.2 molar concentration of a buffering agent selected from citric acid disodium hydrogen phosphate, sodium citrate hydrochloric acid, lactic acid disodium hydrogen phosphate, lactic acid sodium lactate, sodium citrate citric acid and sodium acetate acetic acid, the concentration of buprenorphine being between 0.8 and 10 mg ml of the composition. Buprenorphine is a potent antagonist analgesic with good bioavailability following sublingual administration, useful in the relief of moderate to severe pain and also in the treatment of natcotic addiction. The compositions enable higher doses of buprenorphine to be administered sublingually.